Solid Biosciences Inc.Solid Biosciences Inc.Solid Biosciences Inc.

Solid Biosciences Inc.

No trades
See on Supercharts
Market capitalization
‪377.19 M‬USD
−4.83USD
‪−96.02 M‬USD
‪30.25 M‬
Beta (1Y)
3.78

About Solid Biosciences Inc.

CEO
Alexander Gery Cumbo
Headquarters
Charlestown
Employees (FY)
88
Founded
2013
ISIN
US83422E2046
FIGI
BBG00JN4FXG8
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SLDB is 9.59 USD — it has decreased by 4.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Solid Biosciences Inc. stocks are traded under the ticker SLDB.
Solid Biosciences Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
SLDB stock is 4.55% volatile and has beta coefficient of 3.78. Check out the list of the most volatile stocks — is Solid Biosciences Inc. there?
One year price forecast for Solid Biosciences Inc. has a max estimate of 21.00 USD and a min estimate of 12.00 USD.
SLDB earnings for the last quarter are −1.05 USD whereas the estimation was −1.18 USD which accounts for 11.20% surprise. Estimated earnings for the next quarter are −1.02 USD. See more details about Solid Biosciences Inc. earnings.
Solid Biosciences Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪2.20 M‬ USD. In the next quarter revenue is expected to reach ‪2.20 M‬ USD.
Yes, you can track Solid Biosciences Inc. financials in yearly and quarterly reports right on TradingView.
SLDB stock has fallen by 11.45% compared to the previous week, the month change is a 27.51% fall, over the last year Solid Biosciences Inc. has showed a 95.71% increase.
SLDB net income for the last quarter is ‪−20.34 M‬ USD, while the quarter before that showed ‪−20.98 M‬ USD of net income which accounts for 3.07% change. Track more Solid Biosciences Inc. financial stats to get the full picture.
Today Solid Biosciences Inc. has the market capitalization of ‪377.19 M‬, it has decreased by 1.57% over the last week.
No, SLDB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SLDB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Solid Biosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
SLDB reached its all-time high on Jun 19, 2018 with the price of 822.60 USD, and its all-time low was 1.81 USD and was reached on Oct 30, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 88.00 employees. See our rating of the largest employees — is Solid Biosciences Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Solid Biosciences Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Solid Biosciences Inc. stock shows the neutral signal. See more of Solid Biosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Solid Biosciences Inc. future price: according to them, SLDB price has a max estimate of 21.00 USD and a min estimate of 12.00 USD. Read a more detailed Solid Biosciences Inc. forecast: see what analysts think of Solid Biosciences Inc. and suggest that you do with its stocks.